Xencor XNCR
NASDAQ XNCR
$26.66 +0.03 (+0.13%)
As of: Sep 4, 2026 · 3:20 PM EDT

Xencor (XNCR) Total Debt (QoQ) (2024 - 2026)

Analysis

Xencor (XNCR) Total Debt (QoQ) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Xencor 2.02 Bn 1.64 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.35%
Mar 31, 2026 -9.37%
Dec 31, 2025 -10.06%
Sep 30, 2025 -8.19%
Jun 30, 2025 -6.06%
Mar 31, 2025 -5.64%
Dec 31, 2024 -5.32%
Sep 30, 2024 -3.87%
Jun 30, 2024 -2.89%
Mar 31, 2024 -2.31%